Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	212.52	14.61	4.67
Graham Fair Price	-15.59	16.80	19.91
PEG	415.76	-0.16	0.03
Price/Book	38.43	1.18	0.86
Price/Cash Flow	97.93	-29.34	14.82
Prices/Earnings	121.93	5.27	2.37
Price/Sales	195.55	7.51	2.54
Price/FCF	97.93	-29.34	14.82
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-42.78	0.53	0.93
Operating Margin	31.95	0.47	0.36
ROA	-37.00	0.04	0.06
ROE	0.09	0.06	-37.63
ROIC	0.07	0.05	-32.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	-0.02	2.43
Dividends QOQ	0.00	-0.98	-100.00
EBIT QOQ	0.64	-0.34	-46.28
EPS QOQ	0.77	-0.33	-56.97
FCF QOQ	0.38	-1.74	352.42
Revenue QOQ	0.96	-0.50	-47.37
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	39.05	10.86	-72.18
Days Sales Outstanding (DSO)	14.85	42.35	185.14
Inventory Turnover	2.30	8.28	259.44
Debt/Capitalization	0.15	0.15	-3.13
Quick Ratio	1.51	2.12	39.76
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.98	14.94	6.88
Cash	3.16	4.79	51.83
Capex	-1.50	-0.60	59.86
Free Cash Flow	0.81	-0.60	-25.25
Revenue	4.71	2.36	-49.94
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.02	2.19	8.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.13	-1.19	-811.17
Naive Interpretation	Member

06 - Financial Health · Bad

Rating